Open the News about your Business

Asian Stock: Samsung Biologics

Dec 25, 2024Finance0

Company: Samsung Biologics Company LimitedBloomberg ticker: 207940 KSMarket cap: US$3,051mBackground: Samsung Biologics Company Limited is a contract manufacturer and developer of biopharmaceutical products–drugs made from biological sources. The company currently has four production plants, with a fifth scheduled to open in 2025. Clients include leading global companies likePfizer, GlaxoSmithKline, Eli Lilly, and AstraZeneca.

World Class Benchmarking of Samsung Biologics
 

  • Profitable Growth rank of 4 was up compared to the prior period’s 5th rank
  • This is above average performance compared to 360 large Health Care companies worldwide
  • Profitability rank of 4 was the same as its Growth rank of 4
  • Profitability rank of 4 was up compared to the prior period’s 5th rank
  • This is above average performance compared to peers
  • Growth rank of 4 was up compared to the prior period’s 5th rank
  • This is above average performance compared to peers

    • More By This Author:Asian Stock: ENN Natural Gas
    Asian Stock – MIXI
    Asian Stock: Thai Union Group

    Reviews

    • Total Score 0%
    User rating: 0.00% ( 0
    votes )
    10 Buy And Hold Forever Dividend Stocks

    Related articles

    Leave a Reply

    Your email address will not be published. Required fields are marked *